Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's patents at London's ...

Live Science spoke with Nobel laureate Dr. Drew Weissman and engineer Daeyeon Lee about a new RNA research center they're ...

A large team of microbiologists, pathologists and infectious diseases specialists affiliated with several institutions in the ...

Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) and self-amplifying messenger RNA (sa-mRNA) pioneer Arcturus ...

Researchers have been working on mRNA flu vaccines since before the Covid-19 pandemic, but we may get one for bird flu first.

Since COVID was first reported in December 2019, there have been more than 775 million recorded infections and more than 7 ...

The Seattle oncologist expects many cancer vaccines to become standard care in the next decade, but likely first for breast ...

A head-to-head study has revealed that CSL and Arcturus Therapeutic’s self-amplifying mRNA vaccine can maintain a stronger ...

One of the cornerstones of being prepared for the next pandemic is being in the best position possible to design and deploy a ...

Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday ...